Replies to post #28555 on Entest Group Inc

[Spartanfan1]

According to OTC market website, 8k filed in late January gave Koos 15,000,000 common shares for 15K debt owed to him. Those shares were issued at a price of .001. Translation- this is at .0008 and the company anticipates this going much higher soon. Look out- this time last year- this ran to .01!

[GM_FSJ]

Medistem to Host Investor Update Conference Call
SAN DIEGO, CA–(Marketwired – Jul 19, 2013) Q: What about the 10 dog arthritis study?
A: This was a study where we licensed veterinary use of the ERC to Cook General Biotechnology
together with Entest utilizing canine ERCs. Cook General Biotechnology, together with Entest, they
launched a 10 dog study canine ERCs. The results have not been published yet. The study was being
conducted at a private veterinary clinic in Santa Barbara under an INAD that is held by Cook General
Biotechnology. Medistem did support the study actively, provided the cells to the study and right now
we are still in the process of analyzing the data. Of the 10 dogs, 9 have been successfully dosed and the
follow-up data is in the process of being analyzed.